PE20001351A1 - Composiciones de aciclovir que contienen dimeticona - Google Patents
Composiciones de aciclovir que contienen dimeticonaInfo
- Publication number
- PE20001351A1 PE20001351A1 PE1999001302A PE00130299A PE20001351A1 PE 20001351 A1 PE20001351 A1 PE 20001351A1 PE 1999001302 A PE1999001302 A PE 1999001302A PE 00130299 A PE00130299 A PE 00130299A PE 20001351 A1 PE20001351 A1 PE 20001351A1
- Authority
- PE
- Peru
- Prior art keywords
- aciclovir
- compositions
- dimeticone
- water
- containing dimeticone
- Prior art date
Links
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical group N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004150 aciclovir Drugs 0.000 title abstract 2
- 229960001275 dimeticone Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 title abstract 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 title abstract 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000005846 sugar alcohols Polymers 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UNA FORMULACION FARMACEUTICA TOPICA DE ACEITE EN AGUA QUE COMPRENDE: ACICLOVIR 9-(2-HIDROXIETOXIMETIL)GUANINA, DIMETICONA UTILIZANDOSE DE 0,5% P/P A 1,5%P/P; AL MENOS 30% P/P DE UN ALCOHOL POLIHIDRICO TAL COMO PROPILENGLICOL MISCIBLE EN AGUA. LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO DE ENFERMEDADES VIRALES TAL COMO HERPES
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9828620.6A GB9828620D0 (en) | 1998-12-23 | 1998-12-23 | Medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20001351A1 true PE20001351A1 (es) | 2000-12-14 |
Family
ID=10845017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999001302A PE20001351A1 (es) | 1998-12-23 | 1999-12-21 | Composiciones de aciclovir que contienen dimeticona |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP1140117B1 (es) |
| JP (1) | JP4145493B2 (es) |
| KR (1) | KR100707329B1 (es) |
| CN (2) | CN1191834C (es) |
| AR (1) | AR021993A1 (es) |
| AT (1) | ATE236644T1 (es) |
| AU (1) | AU768989B2 (es) |
| BR (1) | BR9916524A (es) |
| CA (1) | CA2356895A1 (es) |
| CZ (1) | CZ295770B6 (es) |
| DE (2) | DE69906796T2 (es) |
| DK (1) | DK1140117T3 (es) |
| ES (1) | ES2196910T3 (es) |
| GB (2) | GB9828620D0 (es) |
| HK (1) | HK1039275A1 (es) |
| HU (1) | HU230542B1 (es) |
| IL (2) | IL143833A0 (es) |
| NO (1) | NO322090B1 (es) |
| NZ (1) | NZ512457A (es) |
| PE (1) | PE20001351A1 (es) |
| PL (1) | PL196629B1 (es) |
| PT (1) | PT1140117E (es) |
| SI (1) | SI1140117T1 (es) |
| TR (1) | TR200102482T2 (es) |
| TW (1) | TW585768B (es) |
| WO (1) | WO2000038695A2 (es) |
| ZA (1) | ZA200105071B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2005824A1 (de) † | 2007-06-21 | 2008-12-24 | Bayer CropScience AG | Wirkstoffsuspensionen in Glycerin |
| CN102256602A (zh) * | 2008-10-21 | 2011-11-23 | 诺沃德米克斯国际有限公司 | 用于治疗上皮组织的组合物 |
| WO2012107573A1 (en) * | 2011-02-10 | 2012-08-16 | Moberg Derma Ab | Novel formulations for dermal, transdermal and mucosal use 3 |
| WO2015082172A1 (en) * | 2013-12-03 | 2015-06-11 | Zzip Ag | Polydimethylsiloxane for the treatment of viral infections |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2080106B (en) * | 1980-07-18 | 1984-03-07 | Weelcome Foundation Ltd | Acyclovin preparations |
| KR900015739A (ko) * | 1989-04-24 | 1990-11-10 | 히비히 폰 모르쯔 | 비이온성 계면활성제를 함유하는 국소 치료용 항바이러스성 제약 조성물 |
| GB9114939D0 (en) * | 1991-07-11 | 1991-08-28 | Smithkline Beecham Plc | Pharmaceutical formulation |
| FR2728167A1 (fr) * | 1994-12-15 | 1996-06-21 | Cird Galderma | Composition cosmetique ou dermatologique sous forme d'une emulsion eau dans huile a teneur elevee en hydroxyacides |
| FR2737118B1 (fr) * | 1995-07-28 | 1997-09-05 | Oreal | Composition dermatologique ou pharmaceutique, procede de preparation et utilisation |
-
1998
- 1998-12-23 GB GBGB9828620.6A patent/GB9828620D0/en not_active Ceased
-
1999
- 1999-12-21 CN CNB99816156XA patent/CN1191834C/zh not_active Expired - Fee Related
- 1999-12-21 CN CNB2004100420150A patent/CN100415237C/zh not_active Expired - Fee Related
- 1999-12-21 PT PT99965505T patent/PT1140117E/pt unknown
- 1999-12-21 HU HU0104594A patent/HU230542B1/hu not_active IP Right Cessation
- 1999-12-21 GB GB0117795A patent/GB2362105B/en not_active Expired - Lifetime
- 1999-12-21 WO PCT/EP1999/010155 patent/WO2000038695A2/en not_active Ceased
- 1999-12-21 CA CA002356895A patent/CA2356895A1/en not_active Abandoned
- 1999-12-21 KR KR1020017008079A patent/KR100707329B1/ko not_active Expired - Fee Related
- 1999-12-21 TR TR2001/02482T patent/TR200102482T2/xx unknown
- 1999-12-21 HK HK02100122.9A patent/HK1039275A1/zh unknown
- 1999-12-21 JP JP2000590647A patent/JP4145493B2/ja not_active Expired - Fee Related
- 1999-12-21 SI SI9930324T patent/SI1140117T1/xx unknown
- 1999-12-21 DK DK99965505T patent/DK1140117T3/da active
- 1999-12-21 AU AU20997/00A patent/AU768989B2/en not_active Expired
- 1999-12-21 PL PL349505A patent/PL196629B1/pl unknown
- 1999-12-21 IL IL14383399A patent/IL143833A0/xx active IP Right Grant
- 1999-12-21 PE PE1999001302A patent/PE20001351A1/es not_active Application Discontinuation
- 1999-12-21 AT AT99965505T patent/ATE236644T1/de active
- 1999-12-21 DE DE69906796T patent/DE69906796T2/de not_active Expired - Lifetime
- 1999-12-21 EP EP99965505A patent/EP1140117B1/en not_active Expired - Lifetime
- 1999-12-21 BR BR9916524-4A patent/BR9916524A/pt not_active Application Discontinuation
- 1999-12-21 DE DE29924428U patent/DE29924428U1/de not_active Expired - Lifetime
- 1999-12-21 ES ES99965505T patent/ES2196910T3/es not_active Expired - Lifetime
- 1999-12-21 CZ CZ20012332A patent/CZ295770B6/cs not_active IP Right Cessation
- 1999-12-21 NZ NZ512457A patent/NZ512457A/en not_active IP Right Cessation
- 1999-12-22 AR ARP990106684A patent/AR021993A1/es not_active Application Discontinuation
-
2000
- 2000-01-07 TW TW089100208A patent/TW585768B/zh not_active IP Right Cessation
-
2001
- 2001-06-19 IL IL143833A patent/IL143833A/en not_active IP Right Cessation
- 2001-06-20 ZA ZA200105071A patent/ZA200105071B/en unknown
- 2001-06-21 NO NO20013103A patent/NO322090B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR012671A1 (es) | Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos | |
| MX9702699A (es) | Composiciones farmaceuticas. | |
| PE20040549A1 (es) | Composiciones para remover manchas de superficies dentales y metodos de fabricacion y uso de ellas | |
| PE20001032A1 (es) | Composiciones y metodos para tratar enfermedades pulmonares | |
| BR0111206A (pt) | Derivados de arilmetilamina para uso como inibidores de triptase | |
| MX9706046A (es) | Composiciones antitranspirantes a base de agua, desecado rapido y no pegajosas. | |
| ES2161085T3 (es) | Formulaciones que contienen oxaliplatino. | |
| DE69932158D1 (de) | Pharmazeutische zusammenstellungen | |
| ES2184310T3 (es) | Formulacion autoemulsionante para compuestos lipofilos acidos. | |
| SG156624A1 (en) | Organo-gel formulations for therapeutic applications | |
| BRPI0014869B8 (pt) | prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização | |
| AR021539A1 (es) | Preparaciones topicas anhidras para la piel | |
| ES2242218T3 (es) | Composiciones farmaceuticas que contienen aceite de semilla del arbol candil. | |
| AR008927A1 (es) | Una composicion farmaceutica que comprende una sustancia medicinalmente activa insoluble en agua con propiedades mejoradas de disolucion, absorcion, etc., y el procedimiento para prepararla | |
| BR0207872A (pt) | Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração | |
| AR036248A1 (es) | Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica | |
| ES2174591T3 (es) | Composiciones cosmeticas para las axilas con acetato de alquilo inferior. | |
| AR003893A1 (es) | Composicion cosmetica transparente en barra con 2-metil-1,3-propanodiol. | |
| AR029347A1 (es) | Compuesto de adenina, compuesto de isognanina y 2,6-ditioxantina como precursor del mismo, uso de dichos compuestos para preparar una composicion farmaceutica y dicha composicion farmaceutica | |
| BR0315663A (pt) | Formulações de depósito de agentes ativos de aril-heterocìclicos na forma de uma suspensão | |
| BRPI0407652A (pt) | método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição | |
| ES2160680T3 (es) | Utilizacion de un antagonista de sustancia p en una composicion farmaceutica. | |
| ATE213938T1 (de) | Topische pharmazeutische zusammensetzungen die (s)-2-(4-isobutylphenyl) propionsaeure enthalten | |
| KR910000111A (ko) | 치아 구조의 광물질 소실된 부분을 광물질 분재보급 시키기 위한 방법 | |
| AR064262A1 (es) | Composiciones farmaceuticas liquidas que comprenden un compuesto bisfosfonato |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |